- 7 updates
Dr Chris Gallagher, an oncologist at Barts Health NHS Trust, told ITV News that preventative medication will be right for some women, but not for all:
Women who have a family history of breast cancer could soon be offered drugs on the NHS to try to prevent them getting the disease.
Frances Haworth, who had a double mastectomy after discovering a faulty gene that could have seen her breast cancer return, explains how the new drug provision will affect the way her daughter and sister will look to stave off the cancer.
She discusses the treatment options with ITV News Presenter Nina Hossain and Medical Editor Lawrence McGinty.
Healthy women who have a family history of breast cancer could be offered drugs on the NHS to cut their chances of contracting the disease.
Dr Hilary told ITV Daybreak that the offer of medication is a 'historic breakthrough' against cancer prevention.
Currently a draft consultation, he added that the challenge lies with the ability to roll these drugs out across the country.
A previous clinical trial found that tamoxifen, taken for five years, reduced the risk of developing invasive breast cancer by about 50% in post-menopausal women who were at increased risk of getting the disease.
Another trial found that five years of raloxifene reduces breast cancer risk in such women by about 38%.
Under the new plans, high risk post-menopausal women could be offered the drugs for a period of five years unless they have a history of thromboembolic disease or endometrial cancer.
Women with a family history of breast cancer could be offered preventative medication on the NHS under new plans outlined by the health regulator.
Officials are examining whether women who are at "high risk" of developing the disease should be offered hormone therapy to prevent breast cancer.
The National Institute of Health and Clinical Excellence (Nice) has launched a draft consultation to see whether drugs tamoxifen or raloxifene should be offered to high-risk post-menopausal women in England and Wales.